2020-12-30,Codiak Reports Positive Initial Phase 1 Results for exoIL-12 Demonstrating Tolerability and Absence of Systemic IL-12 Exposure in Healthy Volunteers
2020-12-21,New Publication in Molecular Cancer Therapeutics Highlights Data from Preclinical Development of exoIL-12 for the Treatment of Cancer
2020-11-27,Goldman Sachs: These 3 Stocks Could Spike Over 40%
2020-11-23,Codiak BioSciences to Present at the Evercore ISI 3rd Annual HealthCONx Conference
2020-11-19,Codiak BioSciences Reports Third Quarter 2020 Financial Results and Operational Progress
2020-11-09,"Codiak Presents Preclinical Data at SITC 2020 Demonstrating Potential of engEx Engineered Exosomes to Stimulate Targeted, Integrated Anti-Tumor Immunity"
2020-10-23,"Foghorn Therapeutics, the Latest Biotech to Go Public, Rises 13% in Its Market Debut"
2020-10-13,Codiak Announces Pricing of Initial Public Offering
